These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23253750)

  • 21. Non-occupational post exposure prophylaxis as a biobehavioral HIV-prevention intervention.
    Shoptaw S; Rotheram-Fuller E; Landovitz RJ; Wang J; Moe A; Kanouse DE; Reback C
    AIDS Care; 2008 Mar; 20(3):376-81. PubMed ID: 17963091
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV antiretroviral postexposure prophylaxis: a cautionary note.
    Cohen MS; Kashuba AD; Gay C
    Clin Infect Dis; 2005 Nov; 41(10):1514-6. PubMed ID: 16231266
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV seroconversions among male non-occupational post-exposure prophylaxis service users: a data linkage study.
    Pierce AB; Yohannes K; Guy R; Watson KM; Armishaw J; Price B; Hoy JF; Wright EJ; Stoové MA
    Sex Health; 2011 Jun; 8(2):179-83. PubMed ID: 21592431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance.
    Horberg M; Raymond B
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S125-8. PubMed ID: 23253752
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention. Pre-test counseling does not affect risky behaviors, neither does PrEP.
    AIDS Policy Law; 2013 Dec; 29(2):1, 4. PubMed ID: 27024815
    [No Abstract]   [Full Text] [Related]  

  • 26. Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis.
    Cohen SE; Liu AY; Bernstein KT; Philip S
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S80-5. PubMed ID: 23253767
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV.
    Campbell JD; Herbst JH; Koppenhaver RT; Smith DK
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S63-9. PubMed ID: 23253764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-occupational postexposure HIV prophylaxis: clinical issues and public health questions.
    Mayer KH; Kwong J; Singal R; Boswell S
    Med Health R I; 2000 Jul; 83(7):210-3. PubMed ID: 10934823
    [No Abstract]   [Full Text] [Related]  

  • 29. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
    Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
    AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proposed framework to monitor daily oral antiretroviral pre-exposure prophylaxis in the U.S.
    Smith DK; Beltrami J
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S141-6. PubMed ID: 23253756
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing the risk of HIV infection associated with illicit drug use.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2006 Feb; 117(2):566-71. PubMed ID: 16452382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized control trial of personalized cognitive counseling to reduce sexual risk among HIV-infected men who have sex with men.
    Schwarcz SK; Chen YH; Murphy JL; Paul JP; Skinta MD; Scheer S; Vittinghoff E; Dilley JW
    AIDS Care; 2013; 25(1):1-10. PubMed ID: 22568569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.
    Lorente N; Fugon L; Carrieri MP; Andreo C; Le Gall JM; Cook E; Aboulker JP; Capitant C; Molina JM; Spire B
    AIDS Care; 2012; 24(4):468-77. PubMed ID: 22085083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial.
    Bentz L; Enel P; Dunais B; Durant J; Poizot-Martin I; Tourette-Turgis C; Rebillon M; Le Duff F; Dellamonica P; Pradier C
    AIDS Care; 2010 Dec; 22(12):1509-16. PubMed ID: 20824548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV pre-exposure prophylaxis diffusion and implementation issues in nonclinical settings.
    Hosek SG
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S129-32. PubMed ID: 23253753
    [No Abstract]   [Full Text] [Related]  

  • 36. Post exposure prevention.
    Proj Inf Perspect; 2000 Mar; (29):21-2. PubMed ID: 12772670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing the potential benefits of HIV post-exposure prophylaxis.
    Roland ME
    AIDS; 2006 Sep; 20(14):1889-90. PubMed ID: 16954731
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylaxis of HIV infection.
    Omrani AS; Freedman A
    Br Med Bull; 2005; 73-74():93-105. PubMed ID: 16207801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV prevention. Halting HIV/AIDS epidemics.
    Cohen J
    Science; 2011 Dec; 334(6061):1338-40. PubMed ID: 22158796
    [No Abstract]   [Full Text] [Related]  

  • 40. The shifting locus of risk-reduction: the critical role of HIV infected individuals.
    Indyk D; Golub SA
    Soc Work Health Care; 2006; 42(3-4):113-32. PubMed ID: 16687378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.